Advertisement
Original article| Volume 10, 100486, 2023

Magnetic resonance imaging grading of pituitary macroadenoma – SIPAP classification revisited

Open AccessPublished:March 18, 2023DOI:https://doi.org/10.1016/j.ejro.2023.100486

      Abstract

      Background

      Magnetic resonance imaging (MRI) is regarded as the modality of choice in diagnosis of pituitary macroadenomas. Since surgery is the first line therapy for all pituitary adenomas, simple and reproducible MRI classification based on major directions of tumour growth is an essential tool. SIPAP MRI classification for pituitary adenoma describes tumor extension in parasellar, suprasellar, infrasellar, anterior and posterior directions. We, therefore, evaluated reproducibility of SIPAP classification in reporting of pituitary adenomas.

      Methods

      Forty-nine patients with biopsy-proven pituitary macroadenoma were graded according to SIPAP classification. Data was analyzed using Stata version 15. Interobserver variability was calculated using Cohen’s Kappa. Comparison between grading before and after treatment was performed by Chi-square test. P values < 0.05 were considered statistically significant.

      Results

      Individual tumour extensions according to SIPAP for pre- and post-operative grading showed significant difference (p-value <0.001), except for anterior extension. For suprasellar extension, 67.3 % patients had pre-operative grade-3 and 63.3 % had post-operative grade-0. For infrasellar extension, 51.0 % had pre-operative grade-2 and 71.4 % had post-operative grade-0. Anterior, posterior and parasellar extensions showed increased frequency in grade-0 in post-operative stage compared to pre-operative. Substantial inter-observer agreement was achieved for Superior, Inferior, Anterior and Posterior extent with all Kappa statistics values above 0.7 (p-value <0.001).

      Conclusion

      We propose incorporating simple and objective SIPAP classification in routine MR reporting for ideal pituitary tumour delineation, relationship to juxtasellar structures and tumour size, hence facilitating greater success rate in surgical and subsequent clinical management.

      Abbreviations:

      MRI (Magnetic resonance imaging), PA (pituitary adenoma), SE (Spin Echo), CT (Computed tomography), GTR (Gross total resection), MSR (Maximum safe resection)

      Keywords

      1. Introduction

      Pituitary lesions are associated with significant endocrinal abnormalities and need prompt management. The prevalence estimates of pituitary adenomas (PAs) are inconsistent. According to the most recent report from the Central Brain Tumor Registry of the United States, they account for approximately 16.9 % of all brain tumors [
      • Ostrom Q.T.
      • Patil N.
      • Cioffi G.
      • Waite K.
      • Kruchko C.
      • Barnholtz-Sloan J.S.
      CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017.
      ]. MR imaging is regarded as the modality of choice for the diagnosis of pituitary adenomas and there has been a rise in the detection of PAs with the widespread use of MRI [
      • Day P.F.
      • Loto M.G.
      • Glerean M.
      • Picasso M.F.
      • Lovazzano S.
      • Giunta D.H.
      Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
      ].
      First line therapy for all the pituitary adenoma is surgical resection with exception of prolactinoma which shows excellent response to pharmacological therapy [
      • Aiyer R.G.
      • Upreti G.
      Endoscopic endo-nasal trans-sphenoidal approach for pituitary adenomas: a prospective study.
      ]. Transsphenoidal surgery is the approach of choice [
      • Yan J.L.
      • Chang C.N.
      • Chen P.Y.
      Endoscopic transsphenoidal surgery for resection of pituitary macroadenoma: a retrospective study.
      ]. Compared with remission rates of 90 % in microadenomas, macroadenomas with significant extrasellar extension have remission rates of 15–37 % when treated with surgery alone. Radiation therapy and medical treatment often complement surgery [
      • Paek S.H.
      • Downes M.B.
      • Bednarz G.
      • Keane W.M.
      • Werner-Wasik M.
      • Curran Jr, W.J.
      • Andrews D.W.
      Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
      ].
      Simple and reproducible MR classification based on the major directions of tumor growth is an essential tool for surgical intervention. Careful evaluation of tumor extension on preoperative baseline MRI plays a vital role in providing the exact road map for the right surgical approach and maximum safe resection [
      • Shamim M.S.
      • Bari M.E.
      • Khursheed F.
      • Jooma R.
      • Enam S.A.
      Pituitary adenomas: presentations and outcomes in a South Asian country.
      ].
      SIPAP MR classification for pituitary adenomas is derived from the KNOSP-STEINER classification of parasellar growth, to which has been added a grading system for superior, inferior, anterior and posterior tumour extension [
      • Edal A.L.
      • Skjödt K.
      • Nepper-Rasmussen H.J.
      SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.
      ,
      • Knosp E.
      • Steiner E.
      • Kitz K.
      • Matula C.
      Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.
      ].
      We, therefore, propose to incorporate SIPAP classification in routine reporting template of pituitary adenomas, for ideal radiological description of tumour delineation, tumour relationship to juxtasellar structures, and tumour size (height, length and width), hence facilitating greater success rate in surgical and subsequent clinical management.

      2. Methods

      2.1 Patient characteristics

      This study was a retrospective cross-sectional analysis of patients with pituitary macro adenomas who underwent pre and post-operative MRI brain with pituitary protocol between July 2019 to June 2020, interpreted by two neuroradiologist with 8 and 3 years experience at our institution. Inclusion criteria were pre and post-operative MRI with pituitary protocol and histopathologically verified pituitary adenoma. Exclusion criteria were 1) Lack of preoperative imaging. 2) Prior medical therapy, radiation therapy, or chemotherapy, and 3) Inconclusive histopathology result. Based on these criteria, 49 out of 81 patients were enrolled in this study. The mean number of days between pre-operative and post-operative scan was 161 (minimum 1 day and maximum 971 days). This study was exempted and approved by the ethics review committee of our institution (EC No. 2020–4952–12875.).

      2.2 Image acquisition

      MR studies performed on 1.5 and 3T superconducting system (Siemens and Toshiba respectively) with the use of a head coil. The acquisition matrix was 256 × 256 and the field of view 180 mm. Sagittal TI-weighted Spin Echo (SE) and coronal T1-weighted SE sequences before and after intravenous contrast administration acquired according to protocol.

      2.3 Grading system

      The SIPAP classification was proposed by A. L. Edal et al. in 1997 [
      • Edal A.L.
      • Skjödt K.
      • Nepper-Rasmussen H.J.
      SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.
      ] (Table 1). It is based on 6-figure number describing the extension of pituitary adenomas outside the sella. Grading number when read from left to right, there are 6 juxtasellar directions of interest: i) Suprasellar (0−4), ii) Infrasellar (0−2), iii) Parasellar right (0−4), iv) Parasellar left (0−4), v) Anterior (0−1) and 6. Posterior (0−1). Laterality of parasellar extension is taken as right or left and marked individually. T1 post contrast coronal MRI sequence is chosen for grading suprasellar and bilateral parasellar directions of tumour growth, while T1 post contrast sagittal images are used for infrasellar, anterior and posterior extensions. (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5) While reading the scans we made minor modification in posterior grading for improved clarification, that is, we further graded the posterior extension as posterior superior and posterior inferior (0−2). (Fig. 4).
      Table 1SIPAP classification based on the 6-figure registration.
      ExtensionGrading
      SSuprasellar01234
      IInfrasellar012
      PRightParasellar Right01234
      PLeftParasellar Left01234
      AAnterior01
      PPosterior01
      Fig. 1
      Fig. 1Coronal contrast enhanced T1 weighted MRI showing 5 grades of suprasellar extension (arrow). A) Grade 0: No bulge in the suprasellar space. B) Grade 1: Upward bulge of adenoma in suprasellar space without reaching the optic chiasm (arrowhead). C) Grade 2: Adenoma reaching optic chiasm but not displacing it. D) Grade 3: Adenoma displacing optic chiasm. E) Grade 5: Adenoma extension causing obstructive hydrocephalus as evident by dilatation of third and lateral ventricles.
      Fig. 2
      Fig. 2Sagittal contrast enhanced T1 weighted MRI showing 3 grades of infrasellar extension (arrow). A) Grade 0: No inferior bulge with intact floor of sella B) Grade 1: Focal inferior bulge of adenoma as an indirect sign of perforation of dura and floor of sella C) Grade 2: Adenoma extension beneath the sphenoid sinus.
      Fig. 3
      Fig. 3Sagittal contrast enhanced T1 weighted MRI showing 2 grades of anterior extension (arrow). Dotted line represents perpendicular line to the tubercle of sella A) Grade 0: No extension into anterior cranial fossa B) Grade 1: Extension into anterior cranial fossa.
      Fig. 4
      Fig. 4Sagittal contrast enhanced T1 weighted MRI showing 3 grades of posterior extension (arrow). Dotted line represents perpendicular line to the dorsum sella. Solid line represents horizontal line to dorsum sella A) Grade 0: No posterior extension B) Grade 1: Posterior-superior growth C) Grade 2: Posterior-inferior growth.
      Fig. 5
      Fig. 5Coronal contrast enhanced T1 weighted MRI showing 5 grades of parasellar extension (arrow). Dotted lines drawn at the intra and supra cavernous internal carotid arteries A) Grade 0: Extension not beyond the medial tangent. B) Grade 1: Extension up to inter-carotid line. C) Grade 2: Extension up to lateral tangent. D) Grade 3: Extension beyond the lateral tangent E) Grade 4: Total encasement of intra-cavernous carotid artery bilaterally.

      2.4 Image interpretation

      Post contrast T1 Coronal sections were assessed for suprasellar, infrasellar, right parasellar and left parasellar extension of tumor and post contrast T1 sagittal sections were reviewed for anterior and posterior extension of the tumor. Images were reviewed and results were recorded on two separate excel sheet for preoperative and post-operative MRI grading in 49 patients (total 98 scans) by each examiner individually and interobserver rating was calculated. The size of the pituitary tumor was assessed in three dimensions; height and width (craniocaudal and transverse dimensions respectively) were measured on coronal sections and length (anterior-posterior dimension) were measured on sagittal sections and subsequently volume of each tumor was calculated manually.

      2.5 Statistical analysis

      Data are presented as means with standard deviations for continuous variables of pre- and post-procedure brain tumor characteristics (volume, height, length, width) of the patients, and tested for differences using paired t-test. Categorical variables such as patients' demographics and tumor extension grading are reported as frequency and percentages, tested using Chi-square or Fisher's exact test depending upon expected cell count distribution. Interobserver variability was calculated using Cohen’s Kappa. A p-value of < 0.05 was considered as cut off for significance. Data were analyzed using Stata version 15 (StataCorp, College Station, TX: StataCorp LLC.).

      3. Results

      Of the total 49 patients’ data assessed for sellar tumor, 63.3 % comprised of male with a mean age of 49 years (range 16–74) whereas 36.7 % were of female gender with mean age of 47 years (range 24–66).
      Overall, the maximum preoperative volume was found to be 71.82 cm3 whereas the maximum postoperative (residual) volume was 49.50 cm3. Pre and post-operative pituitary tumor volumes were found to be significantly different (14.1 ± 17.7 vs. 4.5 ± 10.4, p-value <0.001). For separate volumetric parameters, length was found to be most significantly different for pre and post-operative measurements (2.4 ± 1.1 vs. 1.3 ± 1.1, p-value <0.001). (Table 2).
      Table 2Pre and post-operative pituitary tumor volume.
      Tumor MeasurementsPre-operative (Mean±SD)Post-operative (Mean±SD)P-value
      Volume
      Paired t-test
      (cm3)
      14.1 ± 17.74.5 ± 10.4<0.001
      Height
      Paired t-test
      (cm)
      2.8 ± 1.31.4 ± 1.3<0.001
      Length
      Paired t-test
      (cm)
      2.4 ± 1.11.3 ± 1.1<0.001
      Width
      Paired t-test
      (cm)
      2.8 ± 1.31.4 ± 1.3<0.001
      a Paired t-test
      Individual assessment of tumor extensions was carried out according to SIPAP classification, each for pre and post-operative grading prevalence. Overall, all extensions were found statistically significantly (p-value <0.001) for pre and post-operative stages except for the anterior extension. For Suprasellar extension, 67.3 % of patient had pre-operative grade 3 and 63.3 % had post-operative grade 0. For Infrasellar extension, 51.0 % had pre-operative grade 2 and 71.4 % had post-operative grade 0. Anterior, Posterior and Parasellar extensions also showed increased frequency in grade 0 in the post-operative stage as compared to the pre-operative stage. (Table 3).
      Table 3Extensions of the tumor and grading according to SIPAP classification.
      Extensions of tumorGradingPre-operative N (%)Post-operative N (%)P-value
      Suprasellar00(0.0)31(63.3)0.00
      16(12.2)4(8.2)
      26(12.2)1(2.0)
      333(67.3)12(24.5)
      44(8.2)1(2.0)
      Infrasellar021(42.9)35(71.4)0.00
      125(51.0)13(26.5)
      23(6.1)1(2.0)
      Anterior038(77.6)43(87.8)0.10
      111(22.5)6(12.2)
      Posterior033(67.3)41(83.7)0.00
      112(24.5)5(10.2)
      24(8.2)3(6.1)
      Paraseller Right017(34.7)30(61.2)0.00
      112(24.5)7(14.3)
      27(14.3)1(2.0)
      38(16.3)6(12.2)
      45(10.2)5(10.2)
      Paraseller Left023(46.9)37(75.5)0.00
      113(26.5)3(6.1)
      25(10.2)4(8.2)
      34(8.2)1(2.0)
      44(8.2)4(8.2)
      High inter-observer agreement of tumor grading was achieved for Superior, Inferior, Anterior and Posterior extent for SIPAP classification. All Kappa statistics values were above 0.7 indicating substantial agreement with significant p-value of < 0.001. Right and left Parasellar had moderate inter-observer agreement with Kappa statistic above 0.51 and 0.54, having significant p-value of < 0.001. (Table 4).
      Table 4Inter-observer Kappa statistics for SIPAP classification for tumor grading (pre-operative) (n = 49).
      SuperiorInferiorAnteriorPosteriorParasellar rightParasellar left
      Kappa0.7690.7710.7660.7240.5120.545
      p-value<0.001<0.001<0.001<0.001<0.001<0.001

      4. Discussion

      HARDY'S classification was the first generally used radiographic classification of pituitary adenomas in which there was indirect assessment of suprasellar extension through pneumoencephalography [
      • Hardy J.
      • Vezina J.L.
      Transsphenoidal neurosurgery of intracranial neoplasm.
      ]. This classification was not suitable for Computed tomography (CT) modality as uni direction of tumour growth was considered. However, from a neurosurgical perspective it was essential to delineate other extrasellar tumour extensions. Therefore, WILSON proposed modified grading system according to the degree of sellar destruction (grade) and extrasellar extension (stage) based on combined imaging and operative findings and emphasizing on tumor size and its extensions. This classification was helpful in designing therapy and had good prognostic value [
      • Wilson C.B.
      A decade of pituitary microsurgery. The Herbert Olivecrona lecture.
      ].
      With the advent of MRI, high resolution imaging and improved soft tissue contrast, a high degree of diagnostic accuracy was achieved [
      • Boxerman J.L.
      • Rogg J.M.
      • Donahue J.E.
      • Machan J.T.
      • Goldman M.A.
      • Doberstein C.E.
      • Preoperative M.R.I.
      evaluation of pituitary macroadenoma: imaging features predictive of successful transsphenoidal surgery.
      ]. In relation to reporting anatomical details and adequate topographical evaluation before surgical planning [
      • Micko A.
      • Oberndorfer J.
      • Weninger W.J.
      • Vila G.
      • Höftberger R.
      • Wolfsberger S.
      • Knosp E.
      Challenging Knosp high-grade pituitary adenomas.
      ]. MRI post contrast coronal sections are the most helpful in demonstrating lateral extension of pituitary macroadenomas and its relation to adjacent parasellar structures especially internal carotid arteries, which are most vulnerable to injure during surgery [
      • Lundin P.
      • Bergström K.
      Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
      ]. Much practical and simple grading system used till date was proposed by KNOSP to predict parasellar tumour growth into the cavernous sinus [
      • Knosp E.
      • Steiner E.
      • Kitz K.
      • Matula C.
      Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.
      ].
      Later in 1997, A.L.Edal et al., proposed SIPAP classification which attempted to combine the KNOSP- HARDY-WILSON classifications. With this combination they were able to offers a precise description of tumour growth in all directions, that is, lateral, upward and downward directions with the addition of forward and backward extensions [
      • Edal A.L.
      • Skjödt K.
      • Nepper-Rasmussen H.J.
      SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.
      ].
      The SIPAP classification does not include tumor size, however it can be added as a supplement for recording and accurate reporting. Lundin and Pederse in 1992 carried out a phantom study and proposed tumor volume assessment in three dimensions - width, length and height, and the formula given for this purpose was 0.5 x width x length x height [
      • Lundin P.
      • Pedersen F.
      Volume of pituitary macroadenomas: assessment by MRI.
      ]. The tumor volume is important to note when there is a need to see the effect of pharmacological treatment of functioning adenomas. However, tumor extensions are more essential as a road map for surgical management and by default the tumor volume is meant to reduce postoperatively due to debulking.
      The SIPAP classification is based on post contrast coronal and sagittal TI-weighted MR images, which is a universally accepted method of imaging pituitary adenomas. It has high diagnostic accuracy and reliability in assessment of tumor growth and useful tool in follow up [
      • Cottier J.P.
      • Destrieux C.
      • Brunereau L.
      • Bertrand P.
      • Moreau L.
      • Jan M.
      • Herbreteau D.
      Cavernous sinus invasion by pituitary adenoma: MR imaging.
      ,
      • Vieira Jr, J.O.
      • Cukiert A.
      • Liberman B.
      Magnetic resonance imaging of cavernous sinus invasion by pituitary adenoma diagnostic criteria and surgical findings.
      ,
      • Dhandapani S.
      • Singh H.
      • Negm H.M.
      • Cohen S.
      • Anand V.K.
      • Schwartz T.H.
      Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery.
      ].
      We had substantial agreement in assessing suprasellar, infrasellar, anterior and posterior extension of tumor in our study. However, there was moderate interobserver rating for parasellar extension which we believe is secondary to a fine line and minimal distance between the medial tangent, intercarotid section and lateral tangent. This aspect can be improved with experience.
      This classification can be used for preoperative tumor assessment to decide about the approach of surgery; postoperative tumor assessment to see the amount of residual and decide further management or surveillance as well as for pharmacologically treated tumors which requires clinical, laboratory and imaging follow up. Transsphenoidal endoscopic procedure is a safer and more effective approach with lesser complication for excision of pituitary adenoma [
      • Laws Jr, E.R.
      • Iuliano S.L.
      • Cote D.J.
      • Woodmansee W.
      • Hsu L.
      • Cho C.H.
      A benchmark for preservation of normal pituitary function after endoscopic transsphenoidal surgery for pituitary macroadenomas.
      ]. Major limitation of transsphenoidal approach is due to its deep and narrow working space [
      • Buchfelder M.
      • Schlaffer S.M.
      • Zhao Y.
      The optimal surgical techniques for pituitary tumors.
      ,
      • Koutourousiou M.
      • Gardner P.A.
      • Fernandez-Miranda J.C.
      • Paluzzi A.
      • Wang E.W.
      • Snyderman C.H.
      Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
      ]. Therefore, transcranial approach is the right choice in a more complicated case of adenoma with lateral or anterior extension because it can provide more radical resection [
      • Buchfelder M.
      • Schlaffer S.M.
      • Zhao Y.
      The optimal surgical techniques for pituitary tumors.
      ,
      • Buchfelder M.
      • Kreutzer J.
      Transcranial surgery for pituitary adenomas.
      ]. In our study there was gross total resection (GTR) in 10 cases while rest of the 39 cases had maximum safe resection (MSR) with residual tumor.
      Endoscopic transphenoidal approach, has a limited window, therefore, before embarking this surgical intervention, it is crucial to know the degree of parasellar extension to avoid injury to carotid arteries; extension of tumor anterior to the tubercle of sella or posteriorly behind the clivus because of their difficult approach; suprasellar extension as it may compress the optic chiasma and may obstruct foramen of Monro causing hydrocephalus; and last but not the least the inferior extension gives an idea of bony sella integrity [
      • Boxerman J.L.
      • Rogg J.M.
      • Donahue J.E.
      • Machan J.T.
      • Goldman M.A.
      • Doberstein C.E.
      • Preoperative M.R.I.
      evaluation of pituitary macroadenoma: imaging features predictive of successful transsphenoidal surgery.
      ].
      This single-center study is limited by its nonrandomized and retrospective design. The application of SIPAP grading for pre-operative and post-operative cases with solitary remnant was straightforward. Post-operative cases with diverse remnants, however, cannot be classified based on this methodology due to ambiguity. Future prospective studies with large study cohort can help in establishing the reliability of this classification with the help of a structured reporting format for interpreting pituitary adenomas.
      We contemplate that the SIPAP classification can give neurosurgeons an in-depth analysis of tumour extension and can predict expected complications during surgery.

      5. Conclusion

      Incorporation of SIPAP grading system in MRI reporting of pituitary adenomas is an effective and reliable tool to delineate tumour extension before treatment, predominantly surgical, providing an excellent road map for the surgeon and curtailing complications. Besides, it can be useful in follow up of tumour recurrence over time.

      Ethics approval statement

      This study was exempted and approved by the ethics review committee of our institution (Aga Khan University) on 25-Aug-2020 (EC No. 2020–4952–12875.).

      Funding statement

      This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

      CRediT authorship contribution statement

      Shayan Anwar: Conceptualization, Data curation, Methodology, Formal analysis, Supervision, Writing – original draft, Writing – review & editing, Kiran Hilal: Data curation, Methodology, Formal analysis, Supervision, Writing – review & editing, Anam Khan: Conceptualization, Data curation, Methodology, Formal analysis, Writing – original draft, Writing – review & editing, Asra Ahmad: Data curation, Methodology, Writing – original draft, Writing – review & editing.

      Declaration of Competing Interest

      The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

      Acknowledgements

      None.

      References

        • Ostrom Q.T.
        • Patil N.
        • Cioffi G.
        • Waite K.
        • Kruchko C.
        • Barnholtz-Sloan J.S.
        CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017.
        Neuro Oncol. 2020; 22: iv1-iv96https://doi.org/10.1093/neuonc/noaa200
        • Day P.F.
        • Loto M.G.
        • Glerean M.
        • Picasso M.F.
        • Lovazzano S.
        • Giunta D.H.
        Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
        Arch Endocrinol. Metab. 2016; 60: 554-561https://doi.org/10.1590/2359-3997000000195
        • Aiyer R.G.
        • Upreti G.
        Endoscopic endo-nasal trans-sphenoidal approach for pituitary adenomas: a prospective study.
        Indian J. Otolaryngol. Head. Neck Surg. 2020; 72: 36-43https://doi.org/10.1007/s12070-019-01725-8
        • Yan J.L.
        • Chang C.N.
        • Chen P.Y.
        Endoscopic transsphenoidal surgery for resection of pituitary macroadenoma: a retrospective study.
        PLoS One. 2021; 16e0255599https://doi.org/10.1371/journal.pone.0255599
        • Paek S.H.
        • Downes M.B.
        • Bednarz G.
        • Keane W.M.
        • Werner-Wasik M.
        • Curran Jr, W.J.
        • Andrews D.W.
        Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
        Int. J. Radiat. Oncol. Biol. Phys. 2005; 61: 795-808https://doi.org/10.1016/j.ijrobp.2004.07.688
        • Shamim M.S.
        • Bari M.E.
        • Khursheed F.
        • Jooma R.
        • Enam S.A.
        Pituitary adenomas: presentations and outcomes in a South Asian country.
        Can. J. Neurol. Sci. 2008; 35: 198-203https://doi.org/10.1017/s0317167100008635
        • Edal A.L.
        • Skjödt K.
        • Nepper-Rasmussen H.J.
        SIPAP--a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior.
        Acta Radio. 1997; 38: 30-36https://doi.org/10.1080/02841859709171238
        • Knosp E.
        • Steiner E.
        • Kitz K.
        • Matula C.
        Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.
        Neurosurgery. 1993; 33 (discussion 617-8): 610-617https://doi.org/10.1227/00006123-199310000-00008. PMID: 8232800
        • Hardy J.
        • Vezina J.L.
        Transsphenoidal neurosurgery of intracranial neoplasm.
        Adv. Neurol. 1976; 15 (PMID: 945663): 261-273
        • Wilson C.B.
        A decade of pituitary microsurgery. The Herbert Olivecrona lecture.
        J. Neurosurg. 1984; 61: 814-833https://doi.org/10.3171/jns.1984.61.5.0814. PMID: 6092567
        • Boxerman J.L.
        • Rogg J.M.
        • Donahue J.E.
        • Machan J.T.
        • Goldman M.A.
        • Doberstein C.E.
        • Preoperative M.R.I.
        evaluation of pituitary macroadenoma: imaging features predictive of successful transsphenoidal surgery.
        AJR Am. J. Roentgenol. 2010; 195: 720-728https://doi.org/10.2214/AJR.09.4128. PMID: 20729452
        • Micko A.
        • Oberndorfer J.
        • Weninger W.J.
        • Vila G.
        • Höftberger R.
        • Wolfsberger S.
        • Knosp E.
        Challenging Knosp high-grade pituitary adenomas.
        J. Neurosurg. 2019; 132: 1739-1746https://doi.org/10.3171/2019.3.JNS19367. PMID: 31151112
        • Lundin P.
        • Bergström K.
        Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
        Acta Radio. 1992; 33 (PMID: 1633042): 323-332
        • Lundin P.
        • Pedersen F.
        Volume of pituitary macroadenomas: assessment by MRI.
        J. Comput. Assist Tomogr. 1992; 16: 519-528https://doi.org/10.1097/00004728-199207000-00004. PMID: 1629407
        • Cottier J.P.
        • Destrieux C.
        • Brunereau L.
        • Bertrand P.
        • Moreau L.
        • Jan M.
        • Herbreteau D.
        Cavernous sinus invasion by pituitary adenoma: MR imaging.
        Radiology. 2000; 215: 463-469https://doi.org/10.1148/radiology.215.2.r00ap18463. PMID: 10796926
        • Vieira Jr, J.O.
        • Cukiert A.
        • Liberman B.
        Magnetic resonance imaging of cavernous sinus invasion by pituitary adenoma diagnostic criteria and surgical findings.
        Arq. Neuropsiquiatr. 2004; 62: 437-443https://doi.org/10.1590/s0004-282×2004000300011. Epub 2004 Jul 20. PMID: 15273840
        • Dhandapani S.
        • Singh H.
        • Negm H.M.
        • Cohen S.
        • Anand V.K.
        • Schwartz T.H.
        Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery.
        World Neurosurg. 2016; 96: 36-46https://doi.org/10.1016/j.wneu.2016.08.088.Epub.2016.Aug.30.PMID:27591098
        • Laws Jr, E.R.
        • Iuliano S.L.
        • Cote D.J.
        • Woodmansee W.
        • Hsu L.
        • Cho C.H.
        A benchmark for preservation of normal pituitary function after endoscopic transsphenoidal surgery for pituitary macroadenomas.
        World Neurosurg. 2016; 91: 371-375https://doi.org/10.1016/j.wneu.2016.04.059.Epub.2016.Apr.23.PMID: 27113402
        • Buchfelder M.
        • Schlaffer S.M.
        • Zhao Y.
        The optimal surgical techniques for pituitary tumors.
        Best. Pr. Res Clin. Endocrinol. Metab. 2019; 33101299https://doi.org/10.1016/j.beem.2019.101299.Epub.2019.Jul.27.PMID:31431397
        • Koutourousiou M.
        • Gardner P.A.
        • Fernandez-Miranda J.C.
        • Paluzzi A.
        • Wang E.W.
        • Snyderman C.H.
        Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
        J. Neurosurg. 2013; 118 (https://doi:10.3171/2012.11.JNS121190.Epub.2013.Jan.4.PMID:23289816): 621-631
        • Buchfelder M.
        • Kreutzer J.
        Transcranial surgery for pituitary adenomas.
        Pituitary. 2008; 11 (PMID: 18421581): 375-384https://doi.org/10.1007/s11102-008-0120-8